(Q39460592)

12 September 2017

title

Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma (English)

1 reference

12 September 2017

Z Liu

1

1 reference

12 September 2017

C Sun

2

1 reference

12 September 2017

Y Zhang

3

1 reference

12 September 2017

Z Ji

4

1 reference

12 September 2017

G Yang

5

1 reference

12 September 2017

publication date

1 January 2011

1 reference

Journal of International Medical Research

12 September 2017

published in

1 reference

12 September 2017

volume

39

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

1319-1332

1 reference

Global cancer statistics, 2002

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Mechanisms of platinum drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

A new resistance mechanism to cisplatin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

PI3K/Akt and apoptosis: size matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

The N-terminus of phosphoinositide 3-kinase-C2beta regulates lipid kinase activity and binding to clathrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

The class II phosphoinositide 3-kinase PI3K-C2beta regulates cell migration by a PtdIns3P dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

The activation of nuclear phosphoinositide 3-kinase C2beta in all-trans-retinoic acid-differentiated HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

Preclinical perspectives on platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900419

10.1177/147323001103900419

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference